Re­gen­eron’s CEO, CSO saw their com­pen­sa­tion slashed in ’16 — but it’s still a jaw-drop­ping sum

Re­gen­eron has long set the pace for set­ting aside the rich­est an­nu­al pay pack­ages in the biotech in­dus­try for its out­spo­ken CEO Len Schleifer and R&D chief George Yan­copou­los. And in 2016 they brought home a moth­er lode of wealth — which still fell far short of what they made in the pre­vi­ous two years.

On Tues­day the biotech $REGN filed their proxy state­ment with the SEC, and the out­spo­ken Schleifer came out with a full com­pen­sa­tion award of $28.3 mil­lion built on an an­nu­al salary of $1.25 mil­lion. His CSO Yan­copou­los earned com­pen­sa­tion to­tal­ing a very close $27.8 mil­lion.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.